Invest Like the Best with Patrick O'Shaughnessy
Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]
· Summarized
Key takeaways
- GLP-1 medicines are at the forefront of a health revolution, proving that proactive, layered approaches to disease prevention can significantly extend healthy lifespan.
- The 'health stack' framework includes five key areas—lipids, cardio-metabolic health, neurodegeneration, inflammation, and blood pressure—each supported by medicines that can potentially add decades to our lives if addressed early.
- Advances in AI are transforming drug discovery by enabling rapid hypothesis generation, molecule design, and fully automated laboratories, paving the way toward a future of scientific superintelligence in biology.
- Grassroots movements and online communities are accelerating personalized approaches to health, including self-experimentation with peptides, which may prompt regulatory adaptations.
- The drug development process, rooted in the scientific method, is becoming faster and more efficient through technological innovations, potentially leading to a revolution in how new medicines are discovered and brought to market.
- Personal motivation rooted in family experiences and systemic healthcare challenges has driven Alex to innovate within the industry, aiming to maximize human impact through strategic investment and enterprise-building.
Summary
The Evolution and Impact of GLP-1 Medicines
Alex discusses the revolutionary progress of GLP-1 medicines, highlighting their role in addressing root causes of chronic diseases like diabetes and cardiovascular issues. The discussion emphasizes how these medicines are not just weight-loss tools but are pivotal in reducing risks of heart attacks, strokes, and kidney damage, and could generate over $100 billion annually. The focus is on their off-label and preventive use, as well as how recent developments like oral formulations and direct-to-consumer models are accelerating adoption and accessibility.
The Concept of the Health Stack and Strategies for Longevity
A core theme is the 'health stack,' a framework of five defensive health layers—lipid management, cardio-metabolic health, neurocognitive health, inflammation, and blood pressure—each supported by existing medicines. Alex emphasizes the importance of proactive, layered approaches to health, integrating lifestyle, monitoring, and medicines to extend healthy lifespan, and discusses how upcoming treatments could add a decade of life by addressing these axes early.
Biological Discoveries and the Future of Drug Development with AI
Alex delves into the scientific and technological advances transforming medicine, especially AI's role in drug discovery. The conversation explores how AI models now can simulate discoveries, identify novel targets, and generate molecules at unprecedented speed, moving the field closer to 'scientific superintelligence.' The potential for fully automated labs and AI-driven experimental cycles could drastically cut development timelines and increase the success rate of new medicines.
The Role of Citizen Pharmacology and Peptides in Health Innovation
A discussion on grassroots movements, such as online communities experimenting with peptides and self-directed drug usage, highlights a shift toward personalized, decentralized health experimentation. Alex reflects on the regulation challenges and the potential for rapid discovery and shared knowledge to transform proactive health management.
The Scientific and Business Process of Medical Innovation
Alex explains the iterative scientific method involved in drug development—from hypothesis generation, laboratory testing, to clinical trials—and how AI accelerates this cycle. He emphasizes the importance of integrating scientific instinct with capital to break through current limitations, and how technology and new data sources like robotic labs and advanced diagnostics will likely lead to a fully automated discovery ecosystem in the coming decade.
Personal Journey and Motivation to Impact Healthcare
Alex shares his personal background, including early influences from his entrepreneurial father and optimistic mother, his education at MIT, and his career at Deerfield. His experiences in healthcare investing and the realization of the systemic issues in drug accessibility and adherence motivated him to co-found Braidwell, aiming to revolutionize how medicines are developed, delivered, and adopted, with a focus on maximizing impact.
Sponsors
- Ramp · Ramp is the only platform built to make your finance team leaner, faster, and better, saving businesses 5% annually on average so you can stay focused on growth. Learn more at ramp.com/invest.
- Vanta · Vanta automated security and compliance for over 16,000 fast-moving companies, helping them watch for risks across vendors and AI tools, and cut vendor assessment time by up to 50%. Invest like the best listeners get a special offer for $1,000 off at vanta.com/invest.
- RidgeLine · RidgeLine is the first end-to-end system of record with embedded AI for investment management firms, replacing legacy technology and enabling faster, smarter operations. Request a demo at ridgeLineapps.com.
- Rogo · Rogo is the AI platform for finance, building agents that understand how bankers and investors work, from diligence to modeling to analysis. Learn more at rogo.ai/invest.
- WorkOS · WorkOS helps SaaS companies add enterprise features quickly to become enterprise-ready, transforming applications in minutes versus months. Visit WorkOS.com.
Show notes
My guest today is Alex Karnal. Alex is the co-founder and managing partner of Braidwell, a life sciences investment firm he built after spending 15 years at Deerfield Management.
The frame we use throughout the episode is the health stack. Alex talks about how most of the diseases that will claim most of our lives are already addressable with medicines that exist today. We work through the five layers of what a defensive health strategy looks like, why GLP-1 medicines represent the first commercial proof that people are ready to be proactive about their health, and why PCSK9 inhibitors may ultimately be the more important drug class even though they get far less attention.
We also get into the science and business of drug discovery itself — why most of the published literature that AI companies are training on cannot be replicated, what it would mean to have a truly agentic scientific lab running 24 hours a day, and why Alex believes we are now on a deterministic curve toward scientific superintelligence in biology.
For the full show notes, transcript, and links to mentioned content, check out the episode page here.
-----
Become a Colossus member to get our quarterly print magazine and private audio experience, including exclusive profiles and early access to select episodes. Subscribe at colossus.com/subscribe.
-----
Ramp’s mission is to help companies manage their spend in a way that reduces expenses and frees up time for teams to work on more valuable projects. Go to ramp.com/invest to sign up for free and get a $250 welcome bonus.
-----
Trusted by thousands of businesses, Vanta continuously monitors your security posture and streamlines audits so you can win enterprise deals and build customer trust without the traditional overhead. Visit vanta.com/invest.
-----
WorkOS is a developer platform that enables SaaS companies to quickly add enterprise features to their applications. Visit WorkOS.com to transform your application into an enterprise-ready solution in minutes, not months.
-----
Rogo is the AI platform for finance. They're building agents for Wall Street that are trained to understand how bankers and investors actually do work: from diligence and modeling, to turning analysis into deliverables. To learn more, visit rogo.ai/invest.
-----
Ridgeline has built a complete, real-time, modern operating system for investment managers. It handles trading, portfolio management, compliance, customer reporting, and much more through an all-in-one real-time cloud platform. Visit ridgelineapps.com.
-----
Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).
Timestamps:
(00:00:00) Welcome to Invest Like the Best
(00:02:29) Intro: Alex Karnal
(00:03:15) State of the Union: GLP1s and Life Sciences
(00:07:01) The Health Stack Framework
(00:12:49) Breaking Down the 5 Defensive Layers
(00:21:18) GLP-1: What's Driving the Inflection
(00:28:28) Diet vs. Drugs: Is Food Enough?
(00:31:15) Barriers to Access: Complexity, Cost & Compliance
(00:35:04) PCSK9: The Closest Thing to a Free Lunch
(00:44:10) Alzheimer's & Neurodegenerative Disease
(00:46:59) Cancer: Early Detection & New Treatments
(00:54:49) Body Imaging & Diagnostic Trade-offs
(00:56:31) How Drugs Are Discovered
(01:02:39) AI in Drug Discovery
(01:10:57) The Automated Lab of the Future
(01:13:05) Peptides & Citizen Pharmacology
(01:16:45) Alex's Background
(01:28:25) Braidwell's Investment Approach
(01:30:39) The Kindest Thing
Follow this show on AudioBrevity and new episodes get summarized for you. Create a free account